|
|
|
Volumn 40, Issue 1040, 1998, Pages 110-112
|
|
New drugs for rheumatoid arthritis
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOTRANSFERASE;
COLESTYRAMINE;
DICLOFENAC;
ETANERCEPT;
IBUPROFEN;
INFLIXIMAB;
LEFLUNOMIDE;
METHOTREXATE;
RIFAMPICIN;
TERIFLUNOMIDE;
TOLBUTAMIDE;
TUMOR NECROSIS FACTOR;
UNCLASSIFIED DRUG;
ALOPECIA;
CLINICAL TRIAL;
DIARRHEA;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MECHANISM;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOMODULATION;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER TOXICITY;
ORAL DRUG ADMINISTRATION;
RASH;
RHEUMATOID ARTHRITIS;
SHORT SURVEY;
SUBCUTANEOUS DRUG ADMINISTRATION;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
CLINICAL TRIALS;
DIARRHEA;
DRUG INTERACTIONS;
FEES, PHARMACEUTICAL;
HUMANS;
IMMUNOGLOBULIN G;
ISOXAZOLES;
RECEPTORS, TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 0032553372
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (9)
|
|
References (8)
|
